Q4 Earnings Forecast for Revvity Issued By Leerink Partnrs

Revvity Inc. (NYSE:RVTY) – Research analysts at Leerink Partnrs cut their Q4 2025 earnings per share (EPS) estimates for shares of Revvity in a research report issued to clients and investors on Sunday, September 14th. Leerink Partnrs analyst P. Souda now forecasts that the company will post earnings of $1.54 per share for the quarter, down from their prior estimate of $1.56. The consensus estimate for Revvity’s current full-year earnings is $4.94 per share. Leerink Partnrs also issued estimates for Revvity’s Q1 2026 earnings at $1.14 EPS and Q3 2026 earnings at $1.35 EPS.

Revvity (NYSE:RVTY) last issued its quarterly earnings data on Monday, July 28th. The company reported $1.18 EPS for the quarter, beating analysts’ consensus estimates of $1.14 by $0.04. Revvity had a return on equity of 7.66% and a net margin of 10.19%.The firm had revenue of $720.28 million for the quarter, compared to analyst estimates of $711.26 million. During the same period in the prior year, the firm posted $1.22 EPS. The company’s revenue for the quarter was up 4.1% on a year-over-year basis. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS.

RVTY has been the topic of a number of other reports. Raymond James Financial reaffirmed an “outperform” rating and issued a $115.00 price objective (down from $120.00) on shares of Revvity in a report on Tuesday, July 29th. Stifel Nicolaus decreased their price objective on Revvity from $120.00 to $110.00 and set a “hold” rating on the stock in a report on Tuesday, July 29th. Wall Street Zen lowered Revvity from a “buy” rating to a “hold” rating in a report on Sunday, August 3rd. Bank of America decreased their price objective on Revvity from $116.00 to $110.00 and set a “buy” rating on the stock in a report on Thursday, June 26th. Finally, Evercore ISI decreased their price objective on Revvity from $116.00 to $115.00 and set an “outperform” rating on the stock in a report on Tuesday, July 8th. Ten equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $120.07.

Revvity Stock Performance

Shares of NYSE RVTY opened at $85.28 on Wednesday. The company has a debt-to-equity ratio of 0.43, a current ratio of 3.33 and a quick ratio of 2.75. The stock’s fifty day moving average price is $90.92 and its two-hundred day moving average price is $95.69. Revvity has a one year low of $81.36 and a one year high of $129.50. The firm has a market cap of $9.90 billion, a price-to-earnings ratio of 36.14, a P/E/G ratio of 2.26 and a beta of 0.94.

Institutional Trading of Revvity

Several institutional investors and hedge funds have recently modified their holdings of the business. Valeo Financial Advisors LLC bought a new stake in shares of Revvity during the 2nd quarter worth $218,000. Osaic Holdings Inc. lifted its position in shares of Revvity by 24.5% during the 2nd quarter. Osaic Holdings Inc. now owns 12,073 shares of the company’s stock worth $1,171,000 after buying an additional 2,374 shares during the last quarter. Orion Porfolio Solutions LLC lifted its position in shares of Revvity by 58.9% during the 2nd quarter. Orion Porfolio Solutions LLC now owns 4,765 shares of the company’s stock worth $461,000 after buying an additional 1,767 shares during the last quarter. Advisory Services Network LLC lifted its position in shares of Revvity by 76.6% during the 2nd quarter. Advisory Services Network LLC now owns 5,636 shares of the company’s stock worth $545,000 after buying an additional 2,445 shares during the last quarter. Finally, State of Wyoming bought a new stake in shares of Revvity during the 2nd quarter worth $402,000. 86.65% of the stock is currently owned by institutional investors.

Revvity Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 7th. Investors of record on Friday, October 17th will be given a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. The ex-dividend date is Friday, October 17th. Revvity’s dividend payout ratio is currently 11.86%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.